Cash Flow from Operating Activities: A company's cash flows from operations.
Black Diamond Therapeutics, Inc. (BDTX) had Cash Flow from Operating Activities of $44.25M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-10.56M |
|
-- |
|
-- |
|
$13.42M |
|
$-13.42M |
|
$2.86M |
|
$-10.56M |
|
$-10.56M |
|
$-10.56M |
|
$-10.56M |
|
$-10.56M |
|
$-10.56M |
|
$-13.42M |
|
$-13.33M |
|
56.80M |
|
56.80M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$146.73M |
|
$1.21M |
|
$19.66M |
|
$166.38M |
|
$16.80M |
|
-- |
|
$16.97M |
|
$33.77M |
|
$132.61M |
|
$132.61M |
|
$132.61M |
|
56.89M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$44.25M |
$-50.61M |
|
$-0.08M |
|
$37.26M |
|
$30.82M |
|
$-6.44M |
|
$3.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$44.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.96% |
|
-7.96% |
|
-6.35% |
|
-7.96% |
|
$2.33 |
|
$0.78 |
|
$0.78 |
|